Topics

MilliporeSigma, ReForm: New licensing deal for excipients

07:36 EST 14 Feb 2020 | SmartBrief

MilliporeSigma and ReForm Biologic have entered into a global licensing deal that will advance research and development of ex -More

Original Article: MilliporeSigma, ReForm: New licensing deal for excipients

NEXT ARTICLE

More From BioPortfolio on "MilliporeSigma, ReForm: New licensing deal for excipients"

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...